Enalapril Maleate

Enalapril Maleate recalls: 6 FDA reports

Recalls involving Enalapril Maleate. What was wrong with each batch, and how the FDA graded the risk.

6Reports
0Class I
5Ongoing
2026-05-13Most recent

What the classes mean

The FDA sorts every recall into one of three classes. The class is the whole story. It is also the part people skip.

ClassWhat the FDA is saying
Class IThere is a reasonable probability that using this will cause serious harm or death.
Class IIIt may cause temporary or reversible harm. Serious harm is unlikely.
Class IIIIt breaks a rule but is unlikely to hurt anyone. Often a labelling fault.

Class II is the bulk of every list here. That matters. A long list of Class II says something different from one Class I.

By class

ClassReports
Class II5
Class III1

By year reported

YearReports
20141
20224
20261
Checking whether it affects you

The lot or code number is what matters. Not the product name. A recall covers specific lots. Yours may not be one of them.

Check the code on your package against the report. The FDA keeps the current list at fda.gov/safety/recalls.

The reports

The text below is quoted from the FDA record word for word.

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Lab

D-0520-2026  ·  Class II  ·  reported 2026-05-13  ·  Ongoing

Why it was recalled
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Product
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Where it went
Nationwide in the USA
How much
675 bottles

Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Indu

D-1177-2022  ·  Class II  ·  reported 2022-07-13  ·  Ongoing

Why it was recalled
CGMP Deviations
Product
Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.
Where it went
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
How much
1,471 bottles

Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Indus

D-1179-2022  ·  Class II  ·  reported 2022-07-13  ·  Ongoing

Why it was recalled
CGMP Deviations
Product
Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Where it went
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
How much
31,260 bottles

Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Indust

D-1178-2022  ·  Class II  ·  reported 2022-07-13  ·  Ongoing

Why it was recalled
CGMP Deviations
Product
Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Where it went
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
How much
9,058

Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Indus

D-1180-2022  ·  Class II  ·  reported 2022-07-13  ·  Ongoing

Why it was recalled
CGMP Deviations
Product
Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Where it went
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
How much
1,424 bottles

Vasotec (enalapril maleate) tablets, RX only, Manufactured by Valeant Pharmaceuticals International, Inc., Ste

D-0019-2015  ·  Class III  ·  reported 2014-10-22  ·  Terminated

Why it was recalled
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.
Product
Vasotec (enalapril maleate) tablets, RX only, Manufactured by Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada 2.5 mg 90 ct - NDC 0187-0140-90 5 mg 30 ct - NDC 0187-0141-30 5 mg 90 ct - NDC 0187-0141-90 10 mg 30 ct - NDC 0187-0142-30 10 mg 90 ct - NDC 0187-0142-90 10 mg 1000 ct - NDC 0187-0142-10 20 mg 30 ct - NDC 0187-0143-30 20 mg 90 ct - NDC 0187-0143-90 20 mg 1000 ct - NDC 0187-0143-10 NDC #'s 64455-140, 64455-141, 64455-142 and 64455-143, 30 ct. bottles, 90 ct. bottles and 1000 ct. bottles
Where it went
Nationwide
How much
205,853 bottles
Read these counts with three things in mind

A firm with more recalls usually makes more products. A contract packer runs hundreds of lines. It will out-recall a company with one product whatever either does. This is not a safety ranking.

Most recalls here are voluntary. A firm found its own fault and pulled the stock. That is the system working. It lands in this database looking the same as a recall the FDA had to push for.

Terminated means the FDA considers the recall finished. It is not a verdict. It does not mean anyone was harmed.

Source: openFDA enforcement reports, retrieved 2026-08-05. FDA dataset last updated 2026-07-29.

← All drug recalls